APYX

Apyx Medical Corporation

Contracts

Total Value

Stock Metrics

0.9%

Short % Float

4.7d to cover · Moderate squeeze

50.5%

Inst % Float

10 holders · 2026-06-30

Nantahala Capital

Top Holder

8.2% of float

29.1M sh

Public Float

29/100

Dilution Score

Medium

39 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

29/100

MEDIUM

Inst: 50.53% · Top: Nantahala Capital Management, LLC

Biotech Analytics

Biotech / Pharma

5.14

Squeeze risk: MODERATEBiotech Grade: F

Insider Buying0

Dilution Risk29

Clinical Trials0

Short Interest10